AMA statement on FDA approval of implant to fight opioid addiction

| 1 Min Read

"The AMA is pleased the FDA approved a new implantable option to help treat patients with substance use disorders. With nearly 2 million Americans needing treatment for opioid use disorder, patients will benefit from increased options for medication-assisted treatment.

 

 

Full press statement available when you sign in

Sign in to the AMA website to get the full version of this press statement. 

AMA membership has its advantages

  • Be a part of the nation's largest physician organization
  • Play a role in shaping the future of health care
  • Enjoy exclusive perks and savings

Not a member? Become a member now.

 

FEATURED STORIES

Clipboard and stethoscope

5 physician leaders on what comes next in healthcare

| 10 Min Read
Four people stand at winding paths

Lifelong learning for physicians enters a new chapter

| 4 Min Read
Weight lifter

This doctor’s journey to lifestyle medicine started at the gym

| 6 Min Read
Two feet, one of them injured and bandaged, with a walking cane

Review in internal medicine: 8 drivers of orthostatic hypotension

| 4 Min Read